Literature DB >> 1691033

Prospective study of colorectal cancer in the west of Scotland: 10-year follow-up.

C S McArdle1, D Hole, D Hansell, L H Blumgart, C B Wood.   

Abstract

Six hundred and forty-five patients presenting with colorectal cancer over a 6-year period were studied prospectively. At the time of presentation almost half the patients had clinical evidence of local tumour fixity and over one-quarter had distant metastases. The overall resectability rate was 70.8 per cent, apparently curative resection being obtained in 52.5 per cent. Overall operative mortality rate was 13.8 per cent, increasing in the elderly. Approximately 70 per cent of patients undergoing 'curative' resections survived for 2 years, 50 per cent survived for 5 years and 40 per cent survived for 10 years. After palliative resection approximately 10 per cent of patients survived for 5 years; only six of 133 patients (4 per cent) undergoing palliative diversion survived for 2 years. This prospective study confirms the advanced stage of colorectal cancer as it presents to a non-specialist centre. Although the poor outlook is largely a consequence of the advanced nature of the disease, there is evidence to suggest that the results of surgical intervention could be improved.

Entities:  

Mesh:

Year:  1990        PMID: 1691033     DOI: 10.1002/bjs.1800770314

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  19 in total

1.  Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection?

Authors:  Edward Leen; Piercarlo Ceccotti; Susan J Moug; Paul Glen; John MacQuarrie; Wilson J Angerson; Thomas Albrecht; Joachim Hohmann; Anja Oldenburg; Jorg Peter Ritz; Paul G Horgan
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

Review 2.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

3.  Patterns of recurrence and survival after laparoscopic and conventional resections for colorectal carcinoma.

Authors:  J E Hartley; B J Mehigan; A W MacDonald; P W Lee; J R Monson
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

Review 4.  Current concepts in metastasis.

Authors:  A K Nigam; M Pignatelli; P B Boulos
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

5.  Survival after rectal cancer: differences between hospital catchment areas. A nationwide study in Sweden.

Authors:  P Blomqvist; A Ekbom; O Nyrén; U B Krusemo; R Bergström; H O Adami
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

6.  Survival after colon cancer 1973-1990 in Sweden. Convergence between catchment areas.

Authors:  P Blomqvist; A Ekbom; O Nyrén; U Krusemo; R Bergström; H O Adami
Journal:  Ann Surg       Date:  1997-02       Impact factor: 12.969

7.  Contrast-enhanced 3D ultrasound in the radiofrequency ablation of liver tumors.

Authors:  Edward Leen; Senthil Kumar; Shahid A Khan; Gavin Low; Keh Oon Ong; Paul Tait; Mike Averkiou
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

8.  Usefulness of contrast-enhanced intraoperative ultrasonography (CE-IOUS) in patients with colorectal liver metastases after preoperative chemotherapy.

Authors:  Andrea Ruzzenente; Simone Conci; Calogero Iacono; Alessandro Valdegamberi; Tommaso Campagnaro; Francesca Bertuzzo; Fabio Bagante; Michela De Angelis; Alfredo Guglielmi
Journal:  J Gastrointest Surg       Date:  2012-10-11       Impact factor: 3.452

9.  Outcome in colorectal adenocarcinoma: two seven-year studies of a population.

Authors:  N L Gordon; A A Dawson; B Bennett; G Innes; O Eremin; P F Jones
Journal:  BMJ       Date:  1993-09-18

10.  Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study.

Authors:  Vicky Goh; Steve Halligan; David M Wellsted; Clive I Bartram
Journal:  Eur Radiol       Date:  2008-08-15       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.